A Study to Evaluate the Immunogenicity, Safety and Tolerability of Quadrivalent Human Papillomavirus Vaccine (V501) in Chinese Girls Aged 9-19 Years and Young Women Aged 20-26 Years (V501-213)

Name: A Study to Evaluate the Immunogenicity, Safety and Tolerability of Quadrivalent Human Papillomavirus Vaccine (V501) in Chinese Girls Aged 9-19 Years and Young Women Aged 20-26 Years (V501-213)
License: Public Domain

Merck Sharp & Dohme LLC

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

prevention of hpv types 16- and 18-related cervical cancer, cervical intraepithelial neoplasia (cin) 1/2/3, and cervical adenocarcinoma in situ

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 272428
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.